Trial intelligence / Profile preview

Nitroglycerin in NSCLC

NCT01210378Phase 2Terminated

Sponsor
Maastro Clinic
Start
Dec 2011
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nitroglycerin in non-small cell lung cancer (NSCLC), sponsored by Maastro Clinic. Started Dec 2011; status: terminated.

02

Drugs

nitroglycerin
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT01210378.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01210378.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call